← All stocks

PODD vs TXG

Insulet Corporation Common Stock vs 10x Genomics Inc. Class A Common Stock. Side-by-side ACCE scores, valuation, profitability, and growth.

PODD
Insulet Corporation Common Stock
Healthcare
140.60
9.75B
TXG
10x Genomics Inc. Class A Common Stock
Healthcare
76.60
9.98B
ACCE scores
PODD
TXG
Composite score
Out of 100
62
42
Growth
88
7
Value
55
15
Quality
89
47
Momentum
17
97
Valuation
PODD
TXG
Price
140.60
76.60
Market cap
9.75B
9.98B
Trailing P/E
26.38
0.00
Forward P/E
18.21
1250.00
EV / EBITDA
15.58
148.50
Dividend yield
0.0%
0.0%
Profitability
PODD
TXG
ROE
26.0%
-9.4%
Net margin
12.3%
-12.2%
Debt / equity
0.63
0.01
Free cash flow
377.70M
130.12M
Growth
PODD
TXG
Revenue growth (YoY)
23.5%
-12.7%
Earnings growth (YoY)
3.3%
0.0%
Analyst target
171.91
52.13
See full analysis